What does apoptosis mean in CLL?

Same author

Okadaic acid-induced apoptosis of HL60 leukemia cells is preceded by destabilization of bcl-2 mRNA and downregulation of bcl-2 protein.

FEBS letters·1998

Same author

New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia.

Annals of the New York Academy of Sciences·1998

Same author

Iron chelation therapy: the need for orally active drugs.

The Journal of laboratory and clinical medicine·1998

Same author

Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.

Oncogene·1998

Same author

Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia: an update of recent scientific reports.

British journal of haematology·1998

Same author

Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients.

Blood·1998

Same journal

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

Leukemia & lymphoma·2026

Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026

Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026

Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026

Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026

Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026

Related Experiment Videos

What does apoptosis mean in CLL?

Related Concept Videos

Okadaic acid-induced apoptosis of HL60 leukemia cells is preceded by destabilization of bcl-2 mRNA and downregulation of bcl-2 protein.

New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia.

Iron chelation therapy: the need for orally active drugs.

Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.

Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia: an update of recent scientific reports.

Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients.

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Related Experiment Videos

What does apoptosis mean in CLL?

Related Concept Videos

Related Articles

Okadaic acid-induced apoptosis of HL60 leukemia cells is preceded by destabilization of bcl-2 mRNA and downregulation of bcl-2 protein.

New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia.

Iron chelation therapy: the need for orally active drugs.

Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.

Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia: an update of recent scientific reports.

Long-term trial of deferiprone in 51 transfusion-dependent iron overloaded patients.

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.